Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (unaudited)

v3.7.0.1
Consolidated Statements of Operations (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Operating expenses        
Research and development $ 3,757,168 $ 7,271,699 $ 7,958,867 $ 11,702,369
General and administrative 2,321,953 2,506,097 4,465,268 7,230,230
Total operating expenses 6,079,121 9,777,796 12,424,135 18,932,599
Loss from operations (6,079,121) (9,777,796) (12,424,135) (18,932,599)
Other income:        
Interest income 45,369 28,379 122,019 71,750
Change in fair value of warrant liabilities 3,196,865 70,395 3,117,064 258,665
Total other income 3,242,234 98,774 3,239,083 330,415
Net loss $ (2,836,887) $ (9,679,022) $ (9,185,052) $ (18,602,184)
Per share information:        
Net loss per share of common stock, basic and diluted $ (0.07) $ (0.35) $ (0.22) $ (0.68)
Basic and diluted weighted average shares outstanding 41,656,006 27,497,424 41,656,006 27,490,667